Efficacy and safety of topical cyclosporine 0.1% in moderate-to-severe dry eye disease refractory to topical cyclosporine 0.05% regimen

PURPOSE: To evaluate the efficacy and safety of 0.1% cyclosporine A cationic emulsion (CsA CE) following prior treatment with 0.05% cyclosporine A anionic emulsion (CsA AE) in moderate to severe dry eye disease (DED). MATERIALS AND METHODS: We retrospectively identified patients with moderate-to-sev...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Yuan-Hsi, Sun, Chi-Chin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220438/
https://www.ncbi.nlm.nih.gov/pubmed/37252163
http://dx.doi.org/10.4103/tjo.TJO-D-22-00140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220438/
https://www.ncbi.nlm.nih.gov/pubmed/37252163
http://dx.doi.org/10.4103/tjo.TJO-D-22-00140

Ejemplares similares